Statistics
Total Visits
Views | |
---|---|
Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: A phase 1 randomized-controlled clinical trial(legacy) | 171 |
Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: A phase 1 randomized-controlled clinical trial(legacy) | 71 |
Total Visits per Month
December 2022 | January 2023 | February 2023 | March 2023 | April 2023 | May 2023 | June 2023 | |
---|---|---|---|---|---|---|---|
Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: A phase 1 randomized-controlled clinical trial | 2 | 1 | 2 | 1 | 0 | 0 | 0 |
File Downloads
Views |
---|
Top Country Views
Views | |
---|---|
Australia | 60 |
United States | 37 |
France | 13 |
Germany | 11 |
China | 8 |
Netherlands | 8 |
Vietnam | 2 |
Ireland | 1 |
Top City Views
Views | |
---|---|
Kaleen | 32 |
Rotterdam | 8 |
Ashburn | 7 |
Boardman | 4 |
Chicago | 4 |
Dearborn | 4 |
Hanoi | 2 |
Sydney | 2 |
Beijing | 1 |
Buffalo | 1 |